The Adiponectin Receptor Agonist ALY688 Prevents Pressure Overload-induced Cardiac Dysfunction And Adverse Cardiac Remodeling

adiponectin analogue (ALY688) - Allysta Pharma

https://www.abstractsonline.com/pp8/#!/10889/presentation/419

Sungji Cho; Keith Dadson; York Univ; Toronto; ON; Canada; Kathryn Crawford; Henry Hsu; Allysta Pharmaceuticals Inc; Seattle; WA; Gary Sweeney; York Univ; Toronto; ON; Canada

Jul 14, 2023